Skip to main content
Erschienen in: Clinical Research in Cardiology 6/2017

11.01.2017 | Original Paper

Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair

verfasst von: Luise Gaede, Johannes Blumenstein, Won-Keun Kim, Christoph Liebetrau, Oliver Dörr, Holger Nef, Christian Hamm, Albrecht Elsässer, Helge Möllmann

Erschienen in: Clinical Research in Cardiology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Aims

We analysed the number of procedures, indications, and in-hospital mortality rates of all patients undergoing isolated surgical aortic valve replacement (sAVR) or transvascular (TV-) and transapical (TA-) transcatheter aortic valve implantation (TAVI) from 2012 to 2015 in Germany.

Methods and results

More than 31,000 aortic valve procedures were performed in 2015 in Germany, representing a total increase of 4.5% over 2014. TV-TAVI accounts for 13,108 of these procedures, with an increase of 21%, whereas the numbers of isolated sAVR and TA-TAVI decreased slightly. Age, frailty, high risk, and patients’ choice were the main reasons for a catheter-based intervention. In 2015, the in-hospital mortality rate after TV-TAVI decreased to 3.4%, approaching that of sAVR (2.9%), despite a considerably higher baseline risk. A stratified analysis according to the German aortic valve (AKL) score demonstrated a further decrease of the in-hospital mortality for TV-TAVI, showing a lower in-hospital mortality rate than expected in all risk groups. Importantly, this also accounts for the lowest risk group with an AKL score <3% showing an in-hospital mortality rate of 1.7%, which is now comparable to that of sAVR (1.5%). In all other risk groups, the in-hospital mortality in patients undergoing TV-TAVI was lower than in patients undergoing sAVR.

Conclusions

Mortality after TV-TAVI keeps decreasing over the last years and equals that of SAVR in the lowest risk cohort in the meanwhile. All TV-TAVI patients have significantly lower observed than expected mortality, which will further lead to a redefinition of standard of care.
Literatur
2.
Zurück zum Zitat Smith C, Leon M, Mack M, Miller D, Moses J, Svnesson L, Tuzcu E, Webb J, Fontana G, Makkar R, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani V, Corso P, Pichard A, Bavaria J, Herrmann H, Akin J, Anderson W, Wang DPS, for the PTI (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198CrossRefPubMed Smith C, Leon M, Mack M, Miller D, Moses J, Svnesson L, Tuzcu E, Webb J, Fontana G, Makkar R, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani V, Corso P, Pichard A, Bavaria J, Herrmann H, Akin J, Anderson W, Wang DPS, for the PTI (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198CrossRefPubMed
6.
Zurück zum Zitat Möllmann H, Bestehorn K, Bestehorn M et al (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis—complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105(6):553–559. doi:10.1007/s00392-016-0962-4 Möllmann H, Bestehorn K, Bestehorn M et al (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis—complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105(6):553–559. doi:10.​1007/​s00392-016-0962-4
7.
Zurück zum Zitat Thyregod HGH, Steinbrüchel DA, Ihlemann N et al (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: one-year results from the all-comers nordic aortic valve intervention (NOTION) randomized clinical trial. J Am Coll Cardiol. doi:10.1016/j.jacc.2015.03.014 Thyregod HGH, Steinbrüchel DA, Ihlemann N et al (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: one-year results from the all-comers nordic aortic valve intervention (NOTION) randomized clinical trial. J Am Coll Cardiol. doi:10.​1016/​j.​jacc.​2015.​03.​014
10.
Zurück zum Zitat Kapadia SR, Leon MB, Makkar RR et al (2015) 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2485–2491. doi:10.1016/S0140-6736(15)60290-2 Kapadia SR, Leon MB, Makkar RR et al (2015) 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2485–2491. doi:10.​1016/​S0140-6736(15)60290-2
11.
Zurück zum Zitat Mack MJ, Leon MB, Smith CR et al (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2477–2484. doi:10.1016/S0140-6736(15)60308-7 Mack MJ, Leon MB, Smith CR et al (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2477–2484. doi:10.​1016/​S0140-6736(15)60308-7
12.
Zurück zum Zitat Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33:2451–2496. doi:10.1093/eurheartj/ehs109 CrossRefPubMed Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33:2451–2496. doi:10.​1093/​eurheartj/​ehs109 CrossRefPubMed
13.
14.
Zurück zum Zitat Eggebrecht H, Mehta RH, Ccb B, Clinical D (2015) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014: on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11:1029–1033. doi:10.4244/EIJY15M09-11 CrossRef Eggebrecht H, Mehta RH, Ccb B, Clinical D (2015) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014: on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11:1029–1033. doi:10.​4244/​EIJY15M09-11 CrossRef
17.
Zurück zum Zitat Kötting J, Schiller W, Beckmann A et al (2013) German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 43:971–977. doi:10.1093/ejcts/ezt114 CrossRefPubMed Kötting J, Schiller W, Beckmann A et al (2013) German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 43:971–977. doi:10.​1093/​ejcts/​ezt114 CrossRefPubMed
18.
Zurück zum Zitat Gummert J, Funkat A, Osswald B et al (2009) EuroScore overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 98:363–369. doi:10.1017/CBO9781107415324.004 CrossRefPubMed Gummert J, Funkat A, Osswald B et al (2009) EuroScore overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 98:363–369. doi:10.​1017/​CBO9781107415324​.​004 CrossRefPubMed
20.
Zurück zum Zitat Durand E, Borz B, Godin M et al (2013) Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 111:891–897. doi:10.1016/j.amjcard.2012.11.056 CrossRefPubMed Durand E, Borz B, Godin M et al (2013) Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 111:891–897. doi:10.​1016/​j.​amjcard.​2012.​11.​056 CrossRefPubMed
21.
Zurück zum Zitat Gaede L, Bartolomeo R, Kley F Van Der et al (2016) Aortic valve stenosis: what do people know? A heart valve disease awareness survey of over 8,800 people aged 60 or over. EuroIntervention 12:883–889. doi:10.4244/EIJY16M06_02 Gaede L, Bartolomeo R, Kley F Van Der et al (2016) Aortic valve stenosis: what do people know? A heart valve disease awareness survey of over 8,800 people aged 60 or over. EuroIntervention 12:883–889. doi:10.​4244/​EIJY16M06_​02
22.
Zurück zum Zitat Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol. doi:10.1016/j.jacc.2015.03.034 PubMed Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol. doi:10.​1016/​j.​jacc.​2015.​03.​034 PubMed
Metadaten
Titel
Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair
verfasst von
Luise Gaede
Johannes Blumenstein
Won-Keun Kim
Christoph Liebetrau
Oliver Dörr
Holger Nef
Christian Hamm
Albrecht Elsässer
Helge Möllmann
Publikationsdatum
11.01.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 6/2017
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-1070-1

Weitere Artikel der Ausgabe 6/2017

Clinical Research in Cardiology 6/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.